Detail Information of Microbiota Influence
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0257 Transporter Info | ||||
Gene Name | SLC2A2 | ||||
Transporter Name | Glucose transporter type 2, liver | ||||
Gene ID | |||||
UniProt ID | |||||
Microbiota Influence of This DT (MBI) | |||||
---|---|---|---|---|---|
Bacteria: Bacillota |
|||||
Genus: Faecalibacterium |
|||||
Faecalibacterium prausnitzii |
Microbe Info |
Click to Show/Hide the Full List 1 Microbe Influence Related to This Species |
|||
Microbe Influence 1 |
Down regulating of SLC2A2 expression in gastrointestinal disturbances expression in children with autism condition | [1] | |||
Regulation Mechanism |
via modulation of the Homeobox protein CDX-2 (CDX2) | Transcription Factor Info | |||
Studied Phenotype |
Gastrointestinal disturbances [ICD11: 1A40] | ||||
Studied Tissue |
Ileum | ||||
In Vivo Model |
Children with autistic disorder and GI disease | ||||
Detailed Description |
The Faecalibacterium prausnitzii has been reported to decrease the expression of the drug transporter SLC2A2. | ||||
Bacteria: Bacteroidota |
|||||
Genus: Phocaeicola |
|||||
Bacteroides Vulgatus |
Microbe Info |
Click to Show/Hide the Full List 1 Microbe Influence Related to This Species |
|||
Microbe Influence 1 |
Down regulating of SLC2A2 expression in gastrointestinal disturbances expression in children with autism condition | [1] | |||
Regulation Mechanism |
via modulation of the Homeobox protein CDX-2 (CDX2) | Transcription Factor Info | |||
Studied Phenotype |
Gastrointestinal disturbances [ICD11: 1A40] | ||||
Studied Tissue |
Ileum | ||||
In Vivo Model |
Children with autistic disorder and GI disease | ||||
Detailed Description |
The Bacteroides Vulgatus has been reported to decrease the expression of the drug transporter SLC2A2. | ||||
Genus: Prevotella |
|||||
Prevotella copri |
Microbe Info |
Click to Show/Hide the Full List 3 Microbe Influence Related to This Species |
|||
Microbe Influence 1 |
Up regulating of SLC2A2 expression in the health condition | [2] , [3] | |||
Regulating Factor |
|||||
Studied Tissue |
Ileum | ||||
In Vivo Model |
Sprague-Dawley rats | ||||
Detailed Description |
The metabolite short-chain fatty acid (acetate) generated from the metabolism of dietary food by the Prevotella copri has been reported to increase the expression of the drug transporter SLC2A2. | ||||
Microbe Influence 2 |
Up regulating of SLC2A2 expression in the health condition | [2] , [3] | |||
Regulating Factor |
|||||
Studied Tissue |
Ileum | ||||
In Vivo Model |
Sprague-Dawley rats | ||||
Detailed Description |
The metabolite short-chain fatty acid (butyrate) generated from the metabolism of dietary food by the Prevotella copri has been reported to increase the expression of the drug transporter SLC2A2. | ||||
Microbe Influence 3 |
Up regulating of SLC2A2 expression in the health condition | [2] , [3] | |||
Regulating Factor |
|||||
Studied Tissue |
Ileum | ||||
In Vivo Model |
Sprague-Dawley rats | ||||
Detailed Description |
The metabolite short-chain fatty acid (propionate) generated from the metabolism of dietary food by the Prevotella copri has been reported to increase the expression of the drug transporter SLC2A2. | ||||
Bacteria: Host unspecified microbiota |
|||||
Genus: Unknown microbiota |
|||||
Host unspecified microbiota |
Click to Show/Hide the Full List 5 Microbe Influence Related to This Species |
||||
Microbe Influence 1 |
Up regulating of SLC2A2 expression in colon cancer condition | [4] | |||
Regulating Factor |
|||||
Studied Phenotype |
Colon cancer [ICD11: 2B90] | ||||
Studied Tissue |
Colon | ||||
In Vitro Model |
Human colon adenocarcinoma cells (Caco2-BBE) | ||||
Detailed Description |
The metabolite butyrate generated from the metabolism of dietary food by the host unspecified microbiota has been reported to increase the expression of the drug transporter SLC2A2. | ||||
Microbe Influence 2 |
Up regulating of SLC2A2 expression in the health condition | [5] | |||
Regulating Factor |
|||||
Studied Tissue |
Liver | ||||
In Vivo Model |
C57BL/6J mice | ||||
Detailed Description |
The metabolite 7-sulfocholic acid generated from the host unspecified microbiota has been reported to increase the expression of the drug transporter SLC2A2. | ||||
Microbe Influence 3 |
Up regulating of SLC2A2 expression in the health condition | [5] | |||
Regulating Factor |
|||||
Studied Tissue |
Liver | ||||
In Vivo Model |
C57BL/6J mice | ||||
Detailed Description |
The metabolite muricholic acid generated from the host unspecified microbiota has been reported to increase the expression of the drug transporter SLC2A2. | ||||
Microbe Influence 4 |
Up regulating of SLC2A2 expression in the health condition | [5] | |||
Regulating Factor |
|||||
Studied Tissue |
Liver | ||||
In Vivo Model |
C57BL/6J mice | ||||
Detailed Description |
The metabolite taurocholic acid generated from the host unspecified microbiota has been reported to increase the expression of the drug transporter SLC2A2. | ||||
Microbe Influence 5 |
Up regulating of SLC2A2 expression in the health condition | [5] | |||
Regulating Factor |
|||||
Studied Tissue |
Liver | ||||
In Vivo Model |
C57BL/6J mice | ||||
Detailed Description |
The metabolite taurodeoxycholic acid generated from the host unspecified microbiota has been reported to increase the expression of the drug transporter SLC2A2. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.